{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:03:03Z","timestamp":1784894583159,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10461-026-05048-y","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:09:42Z","timestamp":1771466982000},"page":"2234-2241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV Pre-exposure Prophylaxis at a Local Public Health Department in the Southern United States: Reducing Barriers, Increasing Access, and Lessons Learned"],"prefix":"10.1007","volume":"30","author":[{"given":"Saurabh","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savannah","family":"Carrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedar","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Mazurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanetta","family":"McKnight-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliyah","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candy","family":"Stancil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie","family":"Allen-Pulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Blowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Paul","family":"Zitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Mortiboy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6632-9587","authenticated-orcid":false,"given":"Jeffrey D.","family":"Jenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"9","key":"5048_CR1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5048_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/aid.2012.0089","volume":"29","author":"JR Castillo-Mancilla","year":"2013","unstructured":"Castillo-Mancilla JR, Zheng JH, Rower JE, Meditz A, Gardner EM, Predhomme J, et al. Tenofovir, emtricitabine, and Tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 2013;29(2):384\u201390.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"5048_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.annepidem.2025.04.017","volume":"106","author":"AP Kourtis","year":"2025","unstructured":"Kourtis AP, Wiener J, Zhu W, R\u00f6nn MM, Salomon J, Huang YA, et al. Estimating the population need for preexposure prophylaxis for HIV in the united States. Ann Epidemiol. 2025;106:48\u201354.","journal-title":"Ann Epidemiol"},{"key":"5048_CR4","unstructured":"Centers for Disease Control and Prevention. National Center for HIV. Viral hepatitis, STD, and tuberculosis prevention. Expanding PrEP coverage in the United States to achieve EHE goals. https:\/\/www.cdc.gov\/nchhstp\/director-letters\/expanding-prep-coverage.html. Accessed 3 Mar 2025."},{"key":"5048_CR5","first-page":"100738","volume":"33","author":"PS Sullivan","year":"2024","unstructured":"Sullivan PS, DuBose SN, Castel AD, Hoover KW, Juhasz M, Guest JL, et al. Equity of PrEP uptake by race, ethnicity, sex and region in the united States in the first decade of prep: a population-based analysis. Lancet Reg Health Am. 2024;33:100738.","journal-title":"Lancet Reg Health Am"},{"key":"5048_CR6","unstructured":"Centers for Disease Control and Prevention. Fast facts: HIV in the United States. https:\/\/www.cdc.gov\/hiv\/data-research\/facts-stats\/index.html. Accessed 3 Mar 2025."},{"key":"5048_CR7","unstructured":"North Carolina Department of Health and Human Services. HIV\/STD\/Hepatitis Surveillance Unit. 2023 North Carolina HIV Surveillance Report. https:\/\/epi.dph.ncdhhs.gov\/cd\/stds\/annualrpts.html. Accessed 3 Mar 2025."},{"issue":"8","key":"5048_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/apc.2019.0054","volume":"33","author":"ME Clement","year":"2019","unstructured":"Clement ME, Johnston BE, Eagle C, Taylor D, Rosengren AL, Goldstein BA, et al. Advancing the HIV Pre-Exposure prophylaxis continuum: A collaboration between a public health department and a federally qualified health center in the Southern united States. AIDS Patient Care STDS. 2019;33(8):366\u201371.","journal-title":"AIDS Patient Care STDS"},{"key":"5048_CR9","unstructured":"Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 update: a clinical practice guideline. https:\/\/stacks.cdc.gov\/view\/cdc\/112360. Accessed 23 Mar 2025."},{"issue":"12","key":"5048_CR10","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1097\/QAD.0000000000002598","volume":"34","author":"K Stankevitz","year":"2020","unstructured":"Stankevitz K, Grant H, Lloyd J, Gomez GB, Kripke K, Torjesen K, et al. Oral preexposure prophylaxis continuation, measurement and reporting. Aids. 2020;34(12):1801\u201311.","journal-title":"Aids"},{"issue":"3","key":"5048_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/cid\/ciaa037","volume":"72","author":"YA Huang","year":"2021","unstructured":"Huang YA, Tao G, Smith DK, Hoover KW. Persistence with human immunodeficiency virus Pre-exposure prophylaxis in the united States, 2012\u20132017. Clin Infect Dis. 2021;72(3):379\u201385.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5048_CR12","doi-asserted-by":"publisher","first-page":"e25252","DOI":"10.1002\/jia2.25252","volume":"22","author":"KC Coy","year":"2019","unstructured":"Coy KC, Hazen RJ, Kirkham HS, Delpino A, Siegler AJ. Persistence on HIV preexposure prophylaxis medication over a 2-year period among a National sample of 7148 PrEP users, united States, 2015 to 2017. J Int AIDS Soc. 2019;22(2):e25252.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"5048_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jadohealth.2016.12.004","volume":"60","author":"SM Wood","year":"2017","unstructured":"Wood SM, Lee S, Barg FK, Castillo M, Dowshen N. Young transgender women\u2019s attitudes toward HIV Pre-exposure prophylaxis. J Adolesc Health. 2017;60(5):549\u201355.","journal-title":"J Adolesc Health"},{"issue":"11","key":"5048_CR14","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1007\/s10461-018-2045-1","volume":"22","author":"THF Whitfield","year":"2018","unstructured":"Whitfield THF, John SA, Rendina HJ, Grov C, Parsons JT. Why I quit Pre-Exposure prophylaxis (PrEP)? A Mixed-Method study exploring reasons for PrEP discontinuation and potential Re-initiation among gay and bisexual men. AIDS Behav. 2018;22(11):3566\u201375.","journal-title":"AIDS Behav"},{"key":"5048_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcv.2017.06.006","volume":"94","author":"E Livant","year":"2017","unstructured":"Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, et al. The fourth generation Alere(TM) HIV combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J Clin Virol. 2017;94:15\u201321.","journal-title":"J Clin Virol"},{"issue":"3","key":"5048_CR16","first-page":"382","volume":"216","author":"C Delaugerre","year":"2017","unstructured":"Delaugerre C, Antoni G, Mahjoub N, Pialoux G, Cua E, Pasquet A, et al. Assessment of HIV screening tests for use in preexposure prophylaxis programs. J Infect Dis. 2017;216(3):382\u20136.","journal-title":"J Infect Dis"},{"issue":"5","key":"5048_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/sextrans-2016-052818","volume":"94","author":"C van Tienen","year":"2018","unstructured":"van Tienen C, Rugebregt S, Scherbeijn S, G\u00f6tz H, van Geurts C. The performance of the Alere HIV combo point-of-care test on stored serum samples; useful for detection of early HIV-1 infections? Sex Transm Infect. 2018;94(5):331\u20133.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"5048_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/sextrans-2015-052491","volume":"93","author":"N Fitzgerald","year":"2017","unstructured":"Fitzgerald N, Cross M, O\u2019Shea S, Fox J. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24. Sex Transm Infect. 2017;93(2):100\u20131.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"5048_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/QAI.0000000000002638","volume":"87","author":"KA Johnson","year":"2021","unstructured":"Johnson KA, Chen MJ, Kohn R, Sachdev D, Bacon O, Lee S, et al. Acute HIV at the time of initiation of Pre-exposure or Post-exposure prophylaxis: impact on drug resistance and clinical outcomes. J Acquir Immune Defic Syndr. 2021;87(2):818\u201325.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5048_CR20","unstructured":"Gilead, Yeztugo (Lenacapavir). Is now the first and only FDA-approved HIV prevention option offering 6 months of protection. https:\/\/www.gilead.com\/news\/news-details\/2025\/yeztugo-lenacapavir-is-now-the-first-and-only-fda-approved-hiv-prevention-option-offering-6-months-of-protection. Accessed 30 June 2025."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05048-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:32:25Z","timestamp":1784892745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05048-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5048"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05048-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"17 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not include factors necessitating patient consent. This work was exempted as non-research by the Durham County Department of Public Health Review Board and approved for publication.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}